课题基金 / 基金详情

Studies on molecular mechanism of mTOR signaling that controls protein synthesis, cell growth, and cell cycle in response to amino acid sufficiency

Studies on molecular mechanism of mTOR signaling that controls protein synthesis, cell growth, and cell cycle in response to amino acid sufficiency
研究 mTOR 信号传导响应氨基酸充足性而控制蛋白质合成、细胞生长和细胞周期的分子机制
批准号:
12480190
负责人:
YONEZAWA Kazuyoshi
金额:
$9.34万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2001

项目摘要

项目成果

YONEZAWA Kazuyoshi的其他基金

相似基金

相关文献

中文摘要
翻译
雷帕霉素的哺乳动物靶标(MTOR)是一种蛋白激酶,通过调节p70S6K(P70S6K)和真核细胞起始因子4E结合蛋白1(4B-BP1)的磷酸化,控制多种细胞功能,包括细胞生长,以响应氨基酸和生长因子。MTOR在体内调节p70S6K和4B-BP1的机制尚不完全清楚。我们发现了一个新的mTOR结合伙伴,Raptor(mTOR的调节相关蛋白),它也能结合p70S6K和4E-BP1,在体内对TOR信号是必不可少的。我们还证明了Raptor通过各自的TOS(保守的TOR信号)基序与p70S6K和4E-BP1结合,这是一个短的保守片段,在体内对这些mTOR底物的氨基酸和mTOR依赖的调节是必需的。在p70S6K或4E-BP1的TOS基序中的一个点突变可以同时取消氨基酸和mTOR调节,选择性地取消它们与猛禽的结合。TOS基序的这种突变也消除了mTOR催化的4E-BP1在体外的所有磷酸化,并取消了mTOR催化的Vitrv中p70S6K磷酸化的猛禽依赖成分。Raptor不改变mTOR的内在催化活性,但似乎是一种mTOR支架蛋白,其与mTOR底物的TOS基序的结合是体内有效的mTOR催化的磷酸化所必需的,也可能是赋予其对雷帕霉素和氨基酸充足的敏感性所必需的。
英文摘要
The mammalian target of rapamycin (mTOR) is a protein kinase that controls multiple cellular functions, including cell growth, in response to amino acids and growth factors, in part by regulating the phosphorylation of p70 S6 kinase (p70S6k) and eukaryotic initiation factor 4E-binding protein 1 (4B-BP1). The mechanisms by which mTOR regulates p70S6k and 4B-BP1 in vivo remain incompletely understood. We identified a novel mTOR-binding partner, raptor (regulatory associated protein of mTOR) that also binds p70S6k and 4E-BP1 and is essential for TOR signaling in vivo. We also demonstrated that raptor binds to p70S6k and 4E-BP1 through their respective TOS (conserved TOR signaling) motife, a short conserved segment previously shown to be required for amino acid- and mTOR-dependent regulation of these mTOR substrates in vivo. A point mutation within the TOS motif of p70S6k or 4E-BP1 known to abolish both amino acid- and mTOR-regulation, selectively abolishes their binding to raptor. This mutation of the TOS motif also eliminates all in vitro mTOR-catalyzed 4E-BP1 phosphorylation and abolishes the raptor-dependent component of mTOR-catalyzed p70S6k phosphorylation in vitrv. Raptor does not alter mTOR's intrinsic catalytic activity, but appears to serve as an mTOR scaffold protein whose binding to the TOS motif of mTOR substrates is necessary for effective mTOR-catalyzed phosphorylation in vivo and perhaps for conferring their sensitivity to rapamycin and amino acid sufficiency.
期刊论文(68)
专著(0)
科研奖励(0)
会议论文
Avruch, J.: "The p70 S6 kinase integrates nutrient and growth signals to control translational capacity"Springer-Verlag. 40 (2001)
Avruch, J.:“p70 S6 激酶整合营养和生长信号来控制翻译能力”Springer-Verlag。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hara, K.: "Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action"Cell. 110. 13 (2002)
Hara, K.:“Raptor,雷帕霉素靶标 (TOR) 的结合伴侣,介导 TOR 作用”细胞。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Yonezawa,K.: "Nutritional regulation of gene and protein expression"Curr.Opin.Clinic.Nutri.Metab.Care. 3. 253-254 (2000)
米泽,K.:“基因和蛋白质表达的营养调节”Curr.Opin.Clinic.Nutri.Metab.Care。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 33 条
    Studies on molecular mechanism of mTOR signaling that controls various cellular functions in response to amino acid sufficiency.
    • 批准号:
      13680714
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.3万
    • 财政年份:
      2001
    • 负责人:
      YONEZAWA Kazuyoshi
    • 依托单位:
    Control of cell cycle checkpoint mediated by mammalian target of rapamycin
    • 批准号:
      10680609
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.11万
    • 财政年份:
      1998
    • 负责人:
      YONEZAWA Kazuyoshi
    • 依托单位:
    国内基金
    海外基金
    NCAPD2通过PI3K-AKT-mTOR-Myc信号轴促进子宫内膜样癌增殖及EMT的机制与靶向治疗研究
    • 批准号:
      JCZRLH202600400
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位:
    沉默Zdhhc23基因降低mTOR 蛋白棕榈酰化抑制黑色素瘤增殖的机制研究
    • 批准号:
      JCZRLH202601126
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位:
    成纤维细胞中NR2F1-AS1协同KRAS通过PI3K/AKT/mTOR途径促进胰腺导管腺癌发展
    基于PI3K/Akt/mTOR信号通路介导的细胞自噬探讨参芪通痹胶囊治疗虚瘀证糖尿病周围神经病变的作用机制研究
    • 批准号:
      2026JJ81891
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      潘娟
    • 依托单位: